EDGAR Filing Documents for 0001104659-20-095654

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001104659-20-095654

Filing Date

2020-08-14

Accepted

2020-08-14 17:16:38

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B4	tm2026741-5_424b4.htm	424B4	195137
2	GRAPHIC	lg_entasis-4clr.jpg	GRAPHIC	432899
3	GRAPHIC	tm2026741d1-tbl_program4clr.jpg	GRAPHIC	2512749
	Complete submission text file	0001104659-20-095654.txt		4248882

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120

Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-241683 | Film No.: 201106590
SIC: 2834 Pharmaceutical Preparations